Aroa Biosurgery (ASX:ARX) is an Australian medical device company that develops and commercialises innovative products for wound healing. The company's flagship product, Endoform®, is a bioresorbable scaffold that is used to promote wound healing in a variety of clinical settings, including general surgery, orthopaedics, and plastic surgery. Aroa Biosurgery's operations are focused on the commercialisation of Endoform® in Australia, New Zealand, and the United States. The company is also developing a pipeline of new products, including Endoform®-LV Plus, a next-generation version of Endoform® with improved properties.